Press Releases

Jul 31, 2017

Veracyte Announces Second Quarter 2017 Financial Results

Read More

Jul 31, 2017

Veracyte Announces Pivotal Clinical Validation Data for Afirma Genomic Sequencing Classifier Presented at World Congress on Thyroid Cancer

Read More

Jul 26, 2017

Veracyte Announces Positive Data From Three Afirma Studies to Be Presented at World Congress on Thyroid Cancer

Read More

Jul 18, 2017

Veracyte to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on Monday, July 31, 2017

Read More

Jun 27, 2017

Veracyte Announces Publication of Study Supporting the Development of Envisia™ Genomic Classifier for IPF in Annals of the American Thoracic Society

Read More

Jun 26, 2017

Veracyte Named a San Francisco Bay Area "Top Workplace" For Fourth Consecutive Year

Read More

Jun 01, 2017

Veracyte to Present at William Blair 2017 Growth Stock Conference

Read More

May 23, 2017

Veracyte Announces Clinical Validation Data Demonstrating Envisia™ Genomic Classifier's Performance in Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2017

Read More

May 18, 2017

Veracyte Announces Anthem Coverage for the Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis

Read More

May 11, 2017

Data Demonstrating Cost-Effectiveness of Veracyte's Percepta® Bronchial Genomic Classifier Published in "Journal of Thoracic Oncology"

Read More